Cohance Lifesciences appoints Ravinath Shetty as Platform COO
Written By : Ruchika Sharma
Published On 2025-11-11 09:45 GMT | Update On 2025-11-11 09:45 GMT
Advertisement
Cohance Lifesciences has announced the appointment of Ravinath Shetty as Platform COO.
With nearly 35 years of leadership in Pharmaceutical Operations, Ravinatha brings a powerful blend of technical depth and proven operational acumen.
"His expertise in operations leadership and site management will be instrumental in driving value and cross-functional excellence across the platform," Cohance shared in a LinkedIn post.
Our comments section is governed by our Comments Policy . By posting comments at Medical Dialogues you automatically agree with our Comments Policy , Terms And Conditions and Privacy Policy .
Disclaimer: This website is primarily for healthcare professionals. The content here does not replace medical advice and should not be used as medical, diagnostic, endorsement, treatment, or prescription advice. Medical science evolves rapidly, and we strive to keep our information current. If you find any discrepancies, please contact us at corrections@medicaldialogues.in. Read our Correction Policy here. Nothing here should be used as a substitute for medical advice, diagnosis, or treatment. We do not endorse any healthcare advice that contradicts a physician's guidance. Use of this site is subject to our Terms of Use, Privacy Policy, and Advertisement Policy. For more details, read our Full Disclaimer here.
NOTE: Join us in combating medical misinformation. If you encounter a questionable health, medical, or medical education claim, email us at factcheck@medicaldialogues.in for evaluation.